Randomized Trial Comparing Dose Reduction and Growth Factor Supplementation for Management of Hematological Side Effects in HIV/Hepatitis C Virus Patients Receiving Pegylated-Interferon and Ribavirin-Reference-Cited by-同舟云学术

Randomized Trial Comparing Dose Reduction and Growth Factor Supplementation for Management of Hematological Side Effects in HIV/Hepatitis C Virus Patients Receiving Pegylated-Interferon and Ribavirin

Published:2011-11-01 Issue:3 Volume:58 Page:261-268
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Talal Andrew H.,Liu Ruei-Chi,Zeremski Marija,Dimova Rositsa,Dove Lorna,Pearce Daniel,Hassanein Tarek,Doonquah Leleka,Aboulafia David,Rodriguez Jorge,Bonilla Hector,Galpin Jeffrey,Aberg Judy A.,Johnston Barbara,Glesby Marshall J.,Jacobson Ira M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference37 articles.

1. Treatment of chronic hepatitis C in human immunodeficiency virushepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin.;Brau;Semin Liver Dis,2005

2. The burden of HIV and hepatitis C virus coinfection.;Puoti;Curr Opin HIV AIDS,2007

3. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.;Carrat;JAMA,2004

4. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.;Torriani;N Engl J Med,2004

5. Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.;Chung;N Engl J Med,2004

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of hepatitis C virus infection in the Asia-Pacific region: an update;The Lancet Gastroenterology & Hepatology;2017-01

2. Haematological manifestations of human immune deficiency virus infection;British Journal of Haematology;2015-10-09

3. Immunomodulators;Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases;2015

4. Feasibility of pegylated interferon and ribavirin in hepatitis C-related cirrhosis with neutropenia or thrombocytopenia;Digestive and Liver Disease;2014-07

5. OPERA: use of pegylated interferon plus ribavirin for treating hepatitis C/HIV co-infection in interferon-naive patients;Antiviral Therapy;2014